Heartflow, Inc. (HTFL) stock
HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30453% above fair value
$45.89−1.18 (-2.51%)
Close on Nov 18, 2026Market cap $3.99BP/E –Yield –
Heartflow gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Heartflow's gross profit for the twelve months ending Jun 30, 2026 was $169.83M, up 51.8% year over year. For fiscal 2025 it was $135.20M, up 43.1% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.20M | +43.1% |
| FY2024 | Dec 31, 2024 | $94.45M | +62.7% |
| FY2023 | Dec 31, 2023 | $58.05M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $53.19M | +62.3% |
| Q1 FY2026 | Mar 31, 2026 | $42.16M | +50.9% |
| Q4 FY2025 | Dec 31, 2025 | $39.06M | +48.8% |
| Q3 FY2025 | Sep 30, 2025 | $35.42M | +42.0% |
| Q2 FY2025 | Jun 30, 2025 | $32.78M | +37.5% |
| Q1 FY2025 | Mar 31, 2025 | $27.94M | – |
| Q4 FY2024 | Dec 31, 2024 | $26.25M | – |
| Q3 FY2024 | Sep 30, 2024 | $24.94M | – |
| Q2 FY2024 | Jun 30, 2024 | $23.84M | – |
See a number that looks wrong?